Skip to main content

Testing version — LOERadar is in active testing. Features and data may change.

Hub News Changes Search

LOERadar

FDA drug patent and exclusivity intelligence, assembled from public records.

Sponsored by

About Terms of Service Privacy Policy Log in

Attorney Advertising

© 2026 LOERadar · An informational research tool drawn from public records; it is not a law firm, does not provide legal advice, and its use does not create an attorney-client relationship.

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE) | LOERadar

Viewing data from:

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

ANDA

AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE | A091431 | HERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INC

6 strengths0 unique patents0 unique exclusivities

Products (6)

Sort:

#001 — EQ 2.5MG BASE;10MG

AB

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Dec 30, 2013

No patent or exclusivity listings for this strength.

#002 — EQ 5MG BASE;10MG

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Dec 30, 2013

#003 — EQ 5MG BASE;20MG

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Dec 30, 2013

#004 — EQ 5MG BASE;40MG

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Dec 30, 2013

#005 — EQ 10MG BASE;20MG

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Dec 30, 2013

#006 — EQ 10MG BASE;40MG

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Dec 30, 2013